A systematic review done for you by a professional service means that PhD-level methodologists handle the technical phases of evidence synthesis, from protocol development and database searching through statistical analysis and manuscript preparation, while you retain full intellectual ownership, authorship, and decision-making authority over the research. This collaborative model follows ICMJE authorship guidelines and is widely used by medical residents, PhD candidates, and clinical researchers who have the domain expertise but need methodological support.
How the Collaborative Model Works in Practice
The term "done for you" does not mean absent from the process. A professional systematic review service operates as a methodological partner, not a ghostwriting operation. You provide the clinical question, domain expertise, and intellectual direction. The service provides the evidence synthesis methodology, statistical analysis, and technical writing.
This division of labor mirrors how research teams function at academic institutions. A principal investigator does not personally run every PCR or analyze every dataset; they direct the research while specialists execute technical components. The International Committee of Medical Journal Editors (ICMJE) recognizes methodological contributions as legitimate collaborative work when properly acknowledged.
The key ethical distinction is transparency. Professional services operate under your name with your full knowledge, input, and approval at every stage. You review outputs, make decisions, and approve the final manuscript. This is fundamentally different from contract cheating or paper mills, which produce work without the stated author's involvement or understanding.
Phase 1: Consultation and Protocol Development
Every professional engagement begins with understanding your research question, target journal, and timeline requirements.
During the initial consultation, the methodologist evaluates whether your question is answerable through a systematic review, whether existing reviews already address it (checking PROSPERO and the Cochrane Library), and whether the likely evidence base is sufficient. This evaluation saves you from investing in a review that cannot succeed.
The understanding pico framework structures your research question into Population, Intervention, Comparison, and Outcome components. This framework directly determines our guide to eligibility criteria, search strategy terms, and outcome measures. Use our try our pico framework builder to draft your question before the consultation.
The protocol document includes: research question, eligibility criteria, database list, draft search strategy, screening process, data extraction plan, risk of bias tools, planned analyses, and any a priori subgroup analyses. The protocol is registered on PROSPERO and time-stamped before screening begins.
Phase 2: Comprehensive Literature Search
The search phase is where professional methodology makes the most measurable difference. A professional search strategy typically searches 4-6 databases with carefully constructed Boolean queries using both controlled vocabulary and free-text terms.
The standard database set includes PubMed/MEDLINE, Embase, Cochrane CENTRAL, and discipline-specific databases. Trial registries (ClinicalTrials.gov, WHO ICTRP) capture unpublished results, and reference list searching of included studies identifies additional citations.
A professional service documents the full search strategy for every database, including the exact search date, number of records retrieved, and any limits applied. This documentation is required for learn about prisma 2020 compliance and journal submission.
Search results are exported to reference management software, deduplicated (our reference deduplication tool explains the process), and imported into screening software like Covidence or Rayyan for the next phase.
Phase 3: Screening and Study Selection
Dual-reviewer screening is a non-negotiable standard. Two independent reviewers assess every title and abstract against the pre-defined eligibility criteria. Studies passing screening undergo full-text review, again by two independent reviewers.
Inter-rater agreement is measured using Cohen's kappa and reported in the manuscript. Disagreements are resolved through discussion or by a third reviewer. This process is documented in a free prisma flow chart generator tool showing the number of records at each stage.
You receive the screening results with a summary of included and excluded studies. Exclusion reasons for full-text rejections are documented individually, as PRISMA 2020 requires reporting reasons for exclusion at the full-text stage.